133 related articles for article (PubMed ID: 8671894)
1. Effects of lipoprotein(a) on mesangial cell proliferation and viability.
Greiber S; Krämer-Guth A; Pavenstädt H; Gutenkunst M; Schollmeyer P; Wanner C
Nephrol Dial Transplant; 1996 May; 11(5):778-85. PubMed ID: 8671894
[TBL] [Abstract][Full Text] [Related]
2. [Atherogenic lipoprotein(a) as a progression factor in glomerular diseases: studies in cultured rat mesangial cells].
Greiber S; Gutenkunst M; Wanner C
Immun Infekt; 1995 Apr; 23(2):50-2. PubMed ID: 7744426
[TBL] [Abstract][Full Text] [Related]
3. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins.
Mondorf UF; Piiper A; Herrero M; Olbrich HG; Bender M; Gross W; Scheuermann E; Geiger H
Kidney Int; 1999 Apr; 55(4):1359-66. PubMed ID: 10201000
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells.
Schulze-Lohoff E; Köhler M; Fees H; Reindl N; Sterzel RB
J Hypertens; 1993 Feb; 11(2):127-34. PubMed ID: 8385171
[TBL] [Abstract][Full Text] [Related]
6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease.
Morishita R; Yamamoto K; Yamada S; Matsushita H; Tomita N; Sakurabayashi I; Kaneda Y; Moriguchi A; Higaki J; Ogihara T
Biochem Biophys Res Commun; 1998 Aug; 249(2):313-20. PubMed ID: 9712693
[TBL] [Abstract][Full Text] [Related]
8. HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism.
Neverov NI; Kaysen GA; Nuccitelli R; Weiss RH
J Am Soc Nephrol; 1997 Aug; 8(8):1247-56. PubMed ID: 9259351
[TBL] [Abstract][Full Text] [Related]
9. Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression.
Grandaliano G; Ranieri E; Monno R; Gesualdo L; Schena F
Exp Nephrol; 1999; 7(3):229-35. PubMed ID: 10352363
[TBL] [Abstract][Full Text] [Related]
10. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
11. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
Mohaupt M; Schoecklmann HO; Schulze-Lohoff E; Sterzel RB
J Hypertens; 1994 Apr; 12(4):401-8. PubMed ID: 8064164
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells.
el-Dahr SS; Dipp S; Yosipiv IV; Baricos WH
Kidney Int; 1996 Dec; 50(6):1850-5. PubMed ID: 8943466
[TBL] [Abstract][Full Text] [Related]
13. Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells.
Simonson MS
Am J Physiol; 1994 Nov; 267(5 Pt 2):F805-15. PubMed ID: 7977784
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Lp(a) on human mesangial cell proliferation, adhesion and migration].
Xu K; Song HM; Wei M
Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):734-6. PubMed ID: 16221338
[TBL] [Abstract][Full Text] [Related]
15. Interactions of low density lipoprotein with rat mesangial cells.
Wasserman J; Santiago A; Rifici V; Holthofer H; Scharschmidt L; Epstein M; Schlondorff D
Kidney Int; 1989 May; 35(5):1168-74. PubMed ID: 2770101
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells.
Orth SR; Weinreich T; Bönisch S; Weih M; Ritz E
Exp Nephrol; 1995; 3(1):23-33. PubMed ID: 7712140
[TBL] [Abstract][Full Text] [Related]
17. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
Song HM; Wei M; Xu K; Li XW
Chin Med J (Engl); 2010 Jan; 123(2):216-20. PubMed ID: 20137374
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
